Literature DB >> 15488759

Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach.

David Gius1, Hengmi Cui, C Matthew Bradbury, John Cook, Deedee K Smart, Shuping Zhao, Lynn Young, Sheri A Brandenburg, Yali Hu, Kheem S Bisht, Allen S Ho, David Mattson, Lunching Sun, Peter J Munson, Eric Y Chuang, James B Mitchell, Andrew P Feinberg.   

Abstract

We tested the hypothesis that the effects on gene expression of altered DNA methylation by 5-aza-2'-deoxycytidine (5-aza-CdR) and genetic (DNMT knockout) manipulation of DNA are similar, and distinct from Trichostatin A (TSA)-induced chromatin decondensation. Surprisingly, the effects of 5-aza-CdR were more similar to those of TSA than to DNMT1, DNMT3B, or double DNMT somatic cell knockout. Furthermore, the effects of 5-aza-CdR were similar at one and five days exposure, suggesting active demethylation or direct influence of both drugs on the stability of methylation and/or chromatin marks. Agents that induce gene activation through hypomethylation may have unintended consequences, since nearly as many genes were downregulated as upregulated after demethylation. In addition, a 75 kb cluster of metallothionein genes was coordinately regulated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488759     DOI: 10.1016/j.ccr.2004.08.029

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  63 in total

1.  Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.

Authors:  Yan Y Sanders; Trygve O Tollefsbol; Brian M Varisco; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

2.  Negative and positive regulation of gene expression by mouse histone deacetylase 1.

Authors:  Gordin Zupkovitz; Julia Tischler; Markus Posch; Iwona Sadzak; Katrin Ramsauer; Gerda Egger; Reinhard Grausenburger; Norbert Schweifer; Susanna Chiocca; Thomas Decker; Christian Seiser
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

Review 3.  The new field of epigenomics: implications for cancer and other common disease research.

Authors:  H T Bjornsson; H Cui; D Gius; M D Fallin; A P Feinberg
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2004

4.  Sequence-specific biosensors report drug-induced changes in epigenetic silencing in living cells.

Authors:  Xudong Huang; Rammohan Narayanaswamy; Kathleen Fenn; Sebastian Szpakowski; Clarence Sasaki; Jose Costa; Pilar Blancafort; Paul M Lizardi
Journal:  DNA Cell Biol       Date:  2012-02-07       Impact factor: 3.311

5.  DNA methylation signatures within the human brain.

Authors:  Christine Ladd-Acosta; Jonathan Pevsner; Sarven Sabunciyan; Robert H Yolken; Maree J Webster; Tiffany Dinkins; Pauline A Callinan; Jian-Bing Fan; James B Potash; Andrew P Feinberg
Journal:  Am J Hum Genet       Date:  2007-11-01       Impact factor: 11.025

6.  MBD4 and MLH1 are required for apoptotic induction in xDNMT1-depleted embryos.

Authors:  Alexey Ruzov; Boris Shorning; Oliver Mortusewicz; Donncha S Dunican; Heinrich Leonhardt; Richard R Meehan
Journal:  Development       Date:  2009-07       Impact factor: 6.868

7.  Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.

Authors:  Cai Guo Ye; George G Chen; Rocky L K Ho; Juanita L Merchant; Ming-Liang He; Paul B S Lai
Journal:  Biochim Biophys Acta       Date:  2013-08-13

8.  DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.

Authors:  Stela S Palii; Beth O Van Emburgh; Umesh T Sankpal; Kevin D Brown; Keith D Robertson
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

Review 9.  A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction.

Authors:  Winston Timp; Andre Levchenko; Andrew P Feinberg
Journal:  Cell Cycle       Date:  2009-02-03       Impact factor: 4.534

10.  Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Authors:  Yeonjoo Jung; Jinah Park; Tai Young Kim; Jung-Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Keith D Robertson; Yung-Jue Bang; Tae-You Kim
Journal:  J Mol Med (Berl)       Date:  2007-06-15       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.